NRR 0.00% 5.6¢ naracoota resources limited

Alcidion's potential performance in the US, page-7

  1. 6,616 Posts.
    lightbulb Created with Sketch. 1
    @cyberbash, this is the best blurb i have found around value proposition and why they have the upper hand here. Hope it helps... Worth a read.

    "Medical Informatics has offered the promise of improved delivery of healthcare but to date the usability of clinical applications has been moderate; the integration with and delivery of patient specific information at the point of care; and the provision of best evidence in a format that supports the clinician at the bedside has been slow to reach its potential.

    The missing component in effective delivery of CDSS has been “Smartforms” that empowers clinicians at the point of care to access and deliver decision support… this is the promise that Alcidion can deliver upon. Smartforms may appear as an electronic replica of the traditional paper forms that have been the mainstay of healthcare administration and patient care since the origins of the healthcare ecosystems, but there is one critical differential — Clinical Decision Support is integrated into the electronic form, capturing and analysing the form to highlight and mitigate clinical risk.

    Miya can guide best practice care, then assist clinicians to efficiently document their decisions, and then monitor for care completion. One of the greatest challenges in healthcare is providing a high quality of interoperability with the myriad of clinical systems that are installed throughout the global healthcare ecosystem, and that’s what Alcidion has done exceptionally well with the Miya Platform. It’s consolidating all of those data sources, selectively processing the highest quality and most clinically appropriate data, and when parts are missing from those sources, matching them together to provide an extremely high quality electronic health record and then passing it through to the CDSS engine.

    One of Miya’s main differences is it can extract data from any clinical, administrative or logistics system in a hospital, including point-of-care devices, and marshal that data in a way that add value to a clinical decision that needs to be made for a patient. Competitive systems do not manage structured clinical data and cannot maximize the use of clinical information to drive CDSS; other ‘eForms’ in the market have limited decision support capabilities, Very few healthcare companies support deep interoperability; unfortunately lack of interoperability is used as a way of locking in users, in contrast the Miya Platform is modern, scalable and highly interoperable that allows Alcidion to develop rapidly new functionality and support of new devices, Competitors rarely support multiple clinical terminology standards (Snomed CT, ICD-10, LOINC, AMT, etc) and enterprise knowledge management.

    With the vast majority of our multi-national competitors, their CDSS is only designed to operate in tandem with the balance of their own infrastructure as often the CDSS Solutions forms part of the EMR platform.

    The Miya Platform is unique because it has been built with the purpose of supporting structured clinical data and advanced CDSS and can operate agnostically to an EMR. When Alcidion deployed the Proof of Concept project at Western Health, one of our key learnings from this deployment was that the “Smartform technology” deployed at the point of care was of immense value to healthcare. It was critical that Smartform technology “morph” into the clinical context of a patient and provide the decision maker with clinical intelligence that they could rapidly and easily absorb. By mimicking traditional paper forms, this completely removed the barrier to change — quite simply delivering CDSS, without altering the existing workflows"
 
watchlist Created with Sketch. Add NRR (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.